2018
DOI: 10.3892/etm.2018.6641
|View full text |Cite
|
Sign up to set email alerts
|

The influence of dexmedetomidine on remifentanil‑induced hyperalgesia and the sex differences

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(20 citation statements)
references
References 36 publications
0
19
0
1
Order By: Relevance
“…NRS scores at the first postoperative hour were lower in group D both at rest and at movement. This is probably a consequence of the alleviation of remifentanil induced hyperalgesia [25], another property of DEX, but this effect didn't make difference 2 hours after operation in this research. In a study during abdominal hysterectomy, intraoperative administration of DEX leaded to higher sedation scores immediately after extubation [26].…”
Section: Discussionmentioning
confidence: 54%
“…NRS scores at the first postoperative hour were lower in group D both at rest and at movement. This is probably a consequence of the alleviation of remifentanil induced hyperalgesia [25], another property of DEX, but this effect didn't make difference 2 hours after operation in this research. In a study during abdominal hysterectomy, intraoperative administration of DEX leaded to higher sedation scores immediately after extubation [26].…”
Section: Discussionmentioning
confidence: 54%
“…Observations of other studies indicated that in order to reduce intra-operatively administered opioid doses, multimodal analgesia or adjuvant drugs may be helpful (7, 8). In order to achieve adequate analgesia, adjuvant drugs including N-methyl-D-aspartate (NMDA) receptor inhibitors such as ketamine, magnesium, dexmedetomidine, or gabapentin can be suggested, as their potentials for pain reduction and OIH/OT prevention is well documented (8-10). Similarly, opioid-free anesthesia appears to be the appropriate option in relation to fentanyl-related OIH/OT.…”
Section: Discussionmentioning
confidence: 99%
“…Despite receiving a moderately high‐dose of dexmedetomidine (2.8 mcg/kg), he still developed OIH. Meanwhile, adult studies have shown dexmedetomidine to prevent OIH at infusion rates ranging from 0.2 to 0.7 mcg kg −1 h −1 and treat OIH at rates ranging from 0.2 to 0.8 mcg kg −1 h −1 21–27 . It is unclear if fentanyl administration by infusion, as we administered, alters the risk of OIH, but infusions often result in the administration of higher cumulative doses of opioids compared to bolus dosing, and the total dose administered certainly impacts the risk of OIH 8 .…”
Section: What Is New and Conclusionmentioning
confidence: 96%
“…Meanwhile, adult studies have shown dexmedetomidine to prevent OIH at infusion rates ranging from 0.2 to 0.7 mcg kg À1 h À1 and treat OIH at rates ranging from 0.2 to 0.8 mcg kg À1 h À1 . [21][22][23][24][25][26][27] It is unclear if fentanyl administration by infusion, as we administered, alters the risk of OIH, but infusions often result in the administration of higher cumulative doses of opioids compared to bolus dosing, and the total dose administered certainly impacts the risk of OIH. 8 Following our patient's subsequent surgery for colostomy takedown, he did not display signs or symptoms of OIH and opioids effectively produced analgesia.…”
Section: What Is New and Conclusionmentioning
confidence: 97%